C-Reactive Protein and Lone Atrial Fibrillation: Potential Confounders

American Journal of Cardiology

Volumn 98, Issue 7, 2006, Pages 991-992

  Boos, Christopher J ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; RISK FACTOR; SINUS RHYTHM; SMOKING; THORAX RADIOGRAPHY; VASCULAR DISEASE;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 33748746854     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.05.005     Document Type: Letter

References (12)

1. Ellinor P.T., Low A., Patton K.K., Shea M.A., and Macrae C.A. C-reactive protein in lone atrial fibrillation. Am J Cardiol 97 (2006) 1346-150
2. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., and Van Wagoner D.R. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
3. Jouven X., Desnos M., Guerot C., and Ducimetiere P. Idiopathic atrial fibrillation as a risk factor for mortality: the Paris Prospective Study I. Eur Heart J 20 (1999) 896-899
4. Boos C.J., and Lip G.Y.H. Is hypertension an inflammatory process?. Curr Pharm Design 12 (2006) 1623-1635
5. Saito M., Ishimitsu T., Minami J., Ono H., Ohrui M., and Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 167 (2003) 73-79
6. Miller M., Zhan M., and Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med 165 (2005) 2063-2068
7. Ridker P.M. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 92 (2003) 17K-22K
8. Tsang T.S., Gersh B.J., Appleton C.P., Tajik A.J., Barnes M.E., Bailey K.R., Oh J.K., Leibson C., Montgomery S.C., and Seward J.B. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40 (2002) 1636-1644
9. Roldan V., Marin F., Blann A.D., Garcia A., Marco P., Sogorb F., and Lip G.Y. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24 (2003) 1373-1380
10. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 43 (2004) 2075-2082
11. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148 (2004) 462-466
12. Boos C.J., Anderson R.A., and Lip G.Y.H. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-1349